21 May 2009
Donor and recipient factors affecting the twelve month graft function
M Krajewska, K Kościelska-Kasprzak, D Drulis-Fajdasz, W Weyde, K Madziarska, O Mazanowska, M Kusztal, M KlingerAnn Transplant 2009; 14(1): 57-57 :: ID: 880406
Abstract
The aim of the study was to evaluate an impact of clinical characteristics potentially important for graft function during the first year.
Material/Methods: The study group encompassed 125 kidney recipients (46 F, 79 M, 46.8±12.3 y.) The observation lasted a minimum of twelve months (30.9±13.0).
Results: The graft function depended on donor and recipient's ages. An influence of gender matching and smoking before transplantation was observed. A negative influence of PRA was noted. An adverse impact of the duration of dialysis on eGFR was found. A signifi cant dependence of DGF and AR was shown. The importance of UA and cholesterol concentration was revealed. Higher CRP concentration was related to higher values of eGFR. In diabetic patients, mean eGFR was lower than in recipients without diabetes. A significant impact of hypertension detected at third month, its intensity, and the number of applied medications were negatively correlated with the eGFR. The presence of proteinuria a month after the procedure was linked to a lower values of GFR. This study indicated a connection between graft function's deterioration and the occurrence of leukopenia and infectious complications.
Conclusions: 1. The novel finding of the study is the positive correlation between CRP level within first three months and eGFR suggesting that higher, but in the normal range CRP is the indicator of more effective IR healing.
2. In addition the multiple factors were revealed associated with recipient
co-morbidities, intensity of the rejection process, and transplanted organ
quality which could be modified by appropriate treatment.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






